Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-255626
Filing Date
2022-09-30
Accepted
2022-09-30 16:45:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d386506dsc13da.htm SC 13D/A 64936
  Complete submission text file 0001193125-22-255626.txt   66520
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address YALELAAN 60 UTRECHT P7 3584 CM
Business Address YALELAAN 60 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Subject) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92425 | Film No.: 221284644
SIC: 2834 Pharmaceutical Preparations